Augment, which lets accredited investors buy and sell shares of late-stage startups, raised $12 million in Series A funding, CEO Noel Moldvai tells Axios Pro exclusively.
Why it matters: Investors are clamoring for new ways to acquire pre-IPO shares as high-growth startups stay private longer.
